| P50 | author | John Guyton | Q37842174 |
| P2093 | author name string | Keyur Patel | |
| | Allen D Roses | |
| | Ornit Chiba-Falek | |
| | Stephen D Gardner | |
| | Jeanette J McCarthy | |
| | Colton Linnertz | |
| P2860 | cites work | Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus | Q21090530 |
| | Dissection of the mitochondrial import and assembly pathway for human Tom40 | Q24337791 |
| | Apolipoprotein 3 allele is associated with persistent hepatitis C virus infection | Q27478309 |
| | Association of apolipoprotein E genotypes with lipid levels and coronary risk | Q28249437 |
| | Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site | Q28264429 |
| | Characterization of the poly-T variant in the TOMM40 gene in diverse populations | Q28732044 |
| | Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease | Q29614952 |
| | The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 |
| | The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 | Q29620136 |
| | Genome-wide association study of Lp-PLA(2) activity and mass in the Framingham Heart Study | Q30484496 |
| | Haploview: Visualization and analysis of SNP genotype data | Q33530583 |
| | APOE mRNA and protein expression in postmortem brain are modulated by an extended haplotype structure | Q33691358 |
| | Genetic variation at a single locus and age of onset for Alzheimer's disease. | Q33870512 |
| | Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection. | Q34065725 |
| | IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C. | Q34142463 |
| | A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease | Q34159318 |
| | The C-terminal alpha-helix domain of apolipoprotein E is required for interaction with nonstructural protein 5A and assembly of hepatitis C virus | Q34190545 |
| | Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms. | Q34295937 |
| | Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels | Q35138365 |
| | Changes in lipid metabolism in chronic hepatitis C. | Q35165949 |
| | Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism | Q35246448 |
| | Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels. | Q35337926 |
| | Functional analysis of APOE locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOE. | Q35696751 |
| | Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt | Q35956085 |
| | Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment | Q36548487 |
| | IL28B and the Control of Hepatitis C Virus Infection | Q37800518 |
| | Assembly of infectious hepatitis C virus particles | Q37819269 |
| | Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study | Q42978491 |
| | Apolipoprotein E4 allele is associated with poor treatment response in hepatitis C virus (HCV) genotype 1. | Q42981658 |
| | Carriage of the apolipoprotein E-epsilon4 allele and histologic outcome of recurrent hepatitis C after antiviral treatment. | Q42987472 |
| | Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. | Q42996760 |
| | Sex and age differences in lipid response to chronic infection with the hepatitis C virus in the United States National Health and Nutrition Examination Surveys | Q42998640 |
| | Beta-lipoproteins influence the serum level of hepatitis C virus. | Q43029944 |
| | Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection | Q43035003 |
| | Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis | Q43048093 |
| | Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection | Q43224504 |
| | Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C. | Q43588122 |
| | Two hepatic enhancers, HCR.1 and HCR.2, coordinate the liver expression of the entire human apolipoprotein E/C-I/C-IV/C-II gene cluster | Q44858774 |
| | Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients | Q45728692 |
| | Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus | Q45731567 |
| | Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study | Q45737816 |
| | Blood lipids of patients with chronic hepatitis: differences related to viral etiology. | Q50949484 |
| | Lipid metabolism in children with chronic hepatitis C, A preliminary report. | Q51483847 |
| | The FibroTest value in discriminating between insignificant and significant fibrosis in chronic hepatitis C patients. The Romanian experience. | Q51918191 |
| | Serum lipid profile of patients with genotype 1b hepatitis C viral infection in Japan | Q73281202 |
| | Serum cholesterol and low-density lipoprotein cholesterol levels as predictors of response to interferon therapy for chronic hepatitis C | Q73728277 |
| | Allelic discrimination using fluorogenic probes and the 5' nuclease assay | Q74618454 |
| | Long-term reversal of hypocholesterolaemia in patients with chronic hepatitis C is related to sustained viral response and viral genotype | Q80054974 |
| | Baseline cholesterol is associated with the response to antiviral therapy in chronic hepatitis C | Q80323229 |
| | Apolipoprotein E genotypes modulate fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases | Q83284557 |
| P433 | issue | 12 | |
| P921 | main subject | pleiotropy | Q1134884 |
| P304 | page(s) | 1911-1920 | |
| P577 | publication date | 2012-08-17 | |
| P1433 | published in | Human Genetics | Q5937167 |
| P1476 | title | Pleiotropy and allelic heterogeneity in the TOMM40-APOE genomic region related to clinical and metabolic features of hepatitis C infection | |
| P478 | volume | 131 | |